When to Start Biologics for pJIA Staff | January 4, 2022 We know that patients with polyarticular juvenile idiopathic arthritis (pJIA) are at risk of poor outcomes, but little evidence currently exists to support a best time to start biologics. STOP-JIA aimed to identify the optimal timing for administration of these agents. To learn more, read the full article "Research on SLE, pJIA & More." According to results from the STOP-JIA trial, when is a good time to start patients diagnosed with polyarticular juvenile idiopathic arthritis on biologic therapy? A. At diagnosis B. Never C. Three months after a conventional synthetic disease-modifying anti-rheumatic drug is started D. In early combination with a conventional synthetic disease-modifying anti-rheumatic drug None Time's up
